CHARACTERISTICS OF CHANGES IN COGNITIVE FUNCTIONS OF THE PATIENTS WITH HYPERTENSIVE DISEASE.

Georgian Med News

SI "Zaporozhye Medical Academy of Postgraduate Education Ministry of Health of Ukraine", Department of Cardiology; Department of Emergency Medical Services; Medical Institute of Sumy State University, Department of Neurosurgery and Neurology, Sumy, Ukraine.

Published: November 2017

Decline of the cognitive functions is one of the modern medicine actual problem. The influence of hypertension as modifiable risk factor in the evolution of cognitive impairment is emphasized in numerous investigations. Almost all the proposed in research literature data were obtained from the investigation of old patients group, who had high indexes of blood pressure and stroke histories. Therefore, we think that it is very impotent to detect the slight and moderate cognitive impairment of hypertensive patients of working age until the expressed clinical signs appear. Objective - determine the age and hypertension duration influence on the evolution of cognitive impairments in patients with essential hypertension of the second stage. There were examined 102 patients with essential hypertension of the second stage, which had not any attendant illnesses. Their average years were about 49,84±0,83 average. Disease duration was approximately 8,78±0,60. According to the purpose of examination all patients were divided by age and disease duration into 3 groups. To study cognitive impairment used a number of neuropsychological tests. Analyzing the MoCA test data of examined patients it should be noted a tendency to decreasing of cognitive function indexes with age increasing. Thus, the patients of the first group have no cognitive impairment. But authentic lowering of MoCA test results may be noted in the patients group of 56 years and higher, up to 6,1% in comparison with the patients under 45 years. The indexes of MoCA test in the group of patients with arterial hypertension duration more than 10 years were authentically lower comparing with the group of patients with disease duration up to 5 years and patients with arterial hypertension duration of 5 to 10 years in 9,9% and in 4,9% accordantly. We have found that with increasing duration of the disease and age the working age patients with essential hypertension of the second stage, significant increase in cognitive impairment was observed. Diagnosing of cognitive impairment is the measure of prevention of dementia in future and it must be an inseparable part of system examination of hypertensive patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cognitive impairment
24
patients
15
patients group
12
hypertension duration
12
patients essential
12
essential hypertension
12
hypertension second
12
second stage
12
disease duration
12
moca test
12

Similar Publications

Inferior frontal sulcal hyperintensities (IFSH) observed on fluid-attenuated inversion recovery (FLAIR) MRI have been proposed as indicators of elevated cerebrospinal fluid waste accumulation in cerebral small vessel disease (CSVD). However, to validate IFSH as a reliable imaging biomarker, further replication studies are required. The objective of this study was to investigate associations between IFSH and CSVD, and their potential repercussions, i.

View Article and Find Full Text PDF

Association of systemic inflammatory markers with white matter hyperintensities and microstructural injury: an analysis of UK Biobank data.

J Psychiatry Neurosci

January 2025

From the Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Qiao, Zhao, Cong, Y. Li, Tian, Yang, Cao, Su); the School of Electrical and Information Engineering, Zhengzhou University of Light Industry, Zhengzhou, China (Zhu); the Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China (P. Li).

Background: White matter damage is closely associated with cognitive and psychiatric symptoms and is prevalent in cerebral small vessel disease (CSVD); although the pathophysiological mechanisms involved in CSVD remain elusive, inflammation plays a crucial role. We sought to investigate the relationship between systemic inflammation markers and imaging markers of CVSD, namely white matter hyperintensity (WMH) and microstructural injury.

Methods: We conducted a study involving both cross-sectional and longitudinal data from the UK Biobank Cohort.

View Article and Find Full Text PDF

Lycopene mitigates paclitaxel-induced cognitive impairment in mice; Insights into Nrf2/HO-1, NF-κB/NLRP3, and GRP-78/ATF-6 axes.

Prog Neuropsychopharmacol Biol Psychiatry

January 2025

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt. Electronic address:

Chemotherapy-induced cognitive impairment, referred to as "chemobrain", is widely acknowledged as a significant adverse effect of cancer therapy. Paclitaxel, a chemotherapeutic drug, has been reported to cause cognitive impairment clinically and in animal models. However, the precise mechanisms are not fully understood.

View Article and Find Full Text PDF

Doxorubicin (DOX)-induced chemobrain has been reported in several studies. Its main culprit is the induction of massive amounts of reactive oxygen species (ROS), hence triggering damage to brain tissues and thus leading to neuroinflammation. Biochanin A (BIO-A) is known to be an antioxidant, anti-inflammatory, and neuroprotective agent.

View Article and Find Full Text PDF

Alterations in Prefrontal Cortical Somatostatin Neurons in Schizophrenia: Evidence for Weaker Inhibition of Pyramidal Neuron Dendrites.

Biol Psychiatry

January 2025

Translational Neuroscience Program, Department of Psychiatry, School of Medicine, University of Pittsburgh; Department of Neuroscience, Dietrich School of Arts and Sciences, University of Pittsburgh; Center for the Neural Basis of Cognition, Carnegie Mellon University. Electronic address:

Background: Certain cognitive processes require inhibition provided by the somatostatin (SST) class of gamma-aminobutyric acid (GABA) neurons in the dorsolateral prefrontal cortex (DLPFC). This inhibition onto pyramidal neuron dendrites depends on both SST and GABA signaling. Although SST mRNA levels are lower in the DLPFC in schizophrenia, it is not known if SST neurons exhibit alterations in the capacity to synthesize GABA, principally via the 67-kilodalton isoform of glutamic acid decarboxylase (GAD67).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!